Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: A randomized placebo-controlled study

American Journal of Obstetrics and Gynecology

Volumn 173, Issue 3 PART 1, 1995, Pages 872-878

  Wide Swensson, Dag H ^a   Ingemarsson, Ingemar ^a   Lunell, Nils Olov ^b   Forman, Axel ^b   Skajaa, Kristijar ^b   Lindberg, Bo ^c   Lindeberg, Solveig ^d   Marsàl, Karel ^e   Andersson, Karl Erik ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

drugs; hypertension; Isradipine; preeclampsia; pregnancy; treatment

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ISRADIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY BLOOD FLOW; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EDEMA; FEMALE; HEADACHE; HEARTBURN; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; UMBILICAL ARTERY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INFANT, NEWBORN; ISRADIPINE; PLACEBOS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PROTEINURIA;

EID: 0029087206     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(95)90357-7     Document Type: Article

References (25)

1. How Swedish obstetricians manage hypertensive disorders in pregnancy
2. Management of severe pre-eclampsia and eclampsia by UK consultants
3. How obstetricians manage hypertension in pregnancy
4. Atenolol in essential hypertension during pregnancy
5. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension
6. A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension
7. The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension
8. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy
9. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects of fetal haemodynamics
10. The use of calcium channel blockers in obstetrics and gynecology, a review
11. Isradipine Reduces Blood Pressure, But Not Placental Blood Flow in Pregnancy Induced Hypertension
12. Effects of isradipine, a new calcium antagonists, on maternal cardiovascular system and uterine activity in labour
13. The classification and definition of the hypertensive disorders of pregnancy
14. Umbilical artery and uteroplacental blood flow velocity waveforms in normal pregnancy—a cross-sectional study
15. Does admission to hospital for bed rest prevent disease progression or improve fetal otucome in pregnancy complicated by non-proteinuric hypertension?
16. Uterine and fetal flow velocity waveforms in hypertensive pregnancy: the effects of a single dose of nifedipine
17. Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat
18. Effects of calcium channel blocker nifedipine on uterine artery flow velocity waveforms
19. Nifedipine and platelets in preeclampsia
20. Second line therapy with nifedipine in severe pregnancy induced hypertension
21. Nifedipine in the treatment of severe preeclampsia
22. A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of pre-eclampsia remote from term
23. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis
24. Hepatotoxicity with the administration of nifedipine for treatment of preterm labor
25. A controlled trial of hypertensive agents in hypertension in pregnancy